|
| 肌少症在肿瘤预后中的作用研究进展 |
| Research progress of the role of sarcopenia in tumour prognosis |
| |
| DOI：10.3969/j.issn.1006-7108.2026.09.016 |
| 中文关键词: 肌少症 肿瘤 骨骼肌指数 患者生存预后 |
| 英文关键词:sarcopenia tumour skeletal muscle index patient survival prognosis |
| 基金项目:国家自然科学基金面上项目（82272742，82473233，82303680）；上海卫生健康委员会领军人才计划（2022LJ019)；科技部国家重点研发计划（2022YFC2503701)；长海医院“固海”计划（GH145-33）；长海医院基础医学研究专项（2023YP22） |
|
| 摘要点击次数: 19 |
| 全文下载次数: 0 |
| 中文摘要: |
| 肌少症作为肿瘤发生发展的独立危险因素，通过骨骼肌指数能够精准量化机体肌肉损耗程度，在肿瘤预防、治疗决策及预后预测中具有关键临床价值。本文系统综述肌少症的评估方法，重点阐述其在肿瘤患者生存预后、治疗预后及术后并发症中的临床应用，旨在为其更好地应用于临床治疗提供依据。 |
| 英文摘要: |
| As an independent risk factor for tumour development, sarcopenia may be accurately quantified by the Skeletal Muscle Index (SMI), which is of key clinical value in tumour prevention, therapeutic decision-making, and prognosis prediction. In this paper, we systematically review the assessment methods of sarcopenia, focusing on its clinical application in the survival prognosis, treatment prognosis, and postoperative complications of tumour patients, aiming to provide a basis for its better application in clinical treatment. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |